Kiniksa Pharmaceuticals, Ltd. (KNSA) Free Cash Flow
Kiniksa Pharmaceuticals, Ltd. (KNSA) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2018-12-31 | -$91.30M |
| 2019-12-31 | -$161.57M |
| 2020-12-31 | -$136.81M |
| 2021-12-31 | -$146.71M |
| 2022-12-31 | $5.70M |
| 2023-12-31 | $13.17M |
| 2024-12-31 | $25.41M |
| 2025-12-31 | $136.42M |
How KNSA compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| KRYS | Krystal Biotech Inc. | $188.91M |
| VCYT | Veracyte Inc. | $126.63M |
| AMPH | Amphastar Pharmaceuticals Inc. | $118.98M |
| ADUS | Addus HomeCare Corporation | $103.79M |
| ICUI | ICU Medical Inc. | $82.83M |
These are five companies in the same sector as KNSA with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Kiniksa Pharmaceuticals, Ltd. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("KNSA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | KNSA | $79.80 | +1.42% | 0.41M |
| 3 | ||||
| 4 | ||||
| 5 |